Patient Safety


The safety of the patients who take our medicines is of fundamental importance to AstraZeneca.

 

We take very seriously our commitment to patient safety. We work continuously to identify and minimise the risks and maximise the benefits of each of our medicines - starting with the discovery of a potential new medicine and continuing throughout its development, launch and marketing

During the development phase, extensive and rigorous pre-clinical and clinical testing is done to establish a potential new medicine's safety and efficacy. After launch, we continue to monitor the use of all our medicines for any side effects not identified during the development process.

A vital aspect of our commitment to patient safety is making sure that accurate and up-to-date information is provided to support effective use of our medicines.

If you would like to report an adverse event for an AstraZeneca product:

 

Report an Event

Australia:                                                                                                                   

Tel: 1800 805 342

(24 hours a day, 7 days a week)

Or you can report electronically using the link below:

New Zealand:

Tel: 09 306 5650

(24 hours a day, 7 days a week)

Or you can report electronically using the link below: